Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Non-Current Assets (2016 - 2025)

Macrogenics (MGNX) has disclosed Non-Current Assets for 14 consecutive years, with $36.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 16.44% to $36.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$66.0 million, a 137.45% decrease, with the full-year FY2025 number at $36.9 million, down 16.44% from a year prior.
  • Non-Current Assets was $36.9 million for Q4 2025 at Macrogenics, down from $38.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $60.7 million in Q1 2021 to a low of -$182.1 million in Q1 2025.
  • A 5-year average of $37.7 million and a median of $48.1 million in 2022 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: soared 122.64% in 2021, then plummeted 498.35% in 2025.
  • Macrogenics' Non-Current Assets stood at $55.7 million in 2021, then increased by 4.67% to $58.3 million in 2022, then dropped by 19.23% to $47.1 million in 2023, then decreased by 6.19% to $44.2 million in 2024, then fell by 16.44% to $36.9 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Non-Current Assets are $36.9 million (Q4 2025), $38.7 million (Q3 2025), and $40.5 million (Q2 2025).